ÂÜÀòÂÒÂ×

Frédéric Desdouits is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as an Independent Board Member at Orano Med, Vice-President at France Biotech, and Chief Executive Officer of TreeFrog Therapeutics, Frédéric is dedicated to advancing innovative therapies for cancer and cell treatments. Previous roles include Non-Executive Director at GENFIT, Managing Director of SEQENS, CEO positions at CU Chemie Uetikon and PCAS, and foundational roles at Citoxlab and Pierre Fabre. Frédéric holds a PhD in Neuropharmacology and Biochemistry and has furthered expertise through various prestigious educational programs, including INSEAD.